Fluorescence-based assay for detecting compounds for modulating the sodium-calcium exchanger (NCX) in 'forward mode'

Carriers are an up-and-coming target family with enormous potential and offer commercial and scientific possibilities. The sodium/calcium exchanger is an important mechanism for the removal of Ca<2+> from various cells. In the heart, said sodium/calcium exchanger extrudes Ca<2+>, which h...

Full description

Saved in:
Bibliographic Details
Main Authors VOLLERT HENNING, GEIBEL SVEN, HUG MARTIN, LICHER THOMAS
Format Patent
LanguageChinese
English
Published 27.01.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Carriers are an up-and-coming target family with enormous potential and offer commercial and scientific possibilities. The sodium/calcium exchanger is an important mechanism for the removal of Ca<2+> from various cells. In the heart, said sodium/calcium exchanger extrudes Ca<2+>, which has entered through Ca<2+> channels for the initiation of contractions, while Na<+> enters the heart cell. It is of considerable interest to identify compounds that modulate the activity of the sodium-calcium exchanger. The present invention relates to a fluorescence-based assay for the detection of compounds for modulating the NCX in 'forward mode'. The invention further relates to a parts set comprising cells that express NCX and to the use of said parts set for testing a compound for activity as an agonist or antagonist of NCX.
Bibliography:Application Number: CN200880008156